News
Emmessar Biotech & Nutrition reports standalone net profit of Rs 0.03 crore in the March 2026 quarter
12-May-2026 | 16:14
Sales decline 10.00% to Rs 0.09 crore
Net profit of Emmessar Biotech & Nutrition reported to Rs 0.03 crore in the quarter ended March 2026 as against net loss of Rs 0.07 crore during the previous quarter ended March 2025. Sales declined 10.00% to Rs 0.09 crore in the quarter ended March 2026 as against Rs 0.10 crore during the previous quarter ended March 2025.
For the full year,net profit rose 37.50% to Rs 0.44 crore in the year ended March 2026 as against Rs 0.32 crore during the previous year ended March 2025. Sales declined 39.34% to Rs 0.37 crore in the year ended March 2026 as against Rs 0.61 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 0.09 | 0.10 | -10 | 0.37 | 0.61 | -39 |
| OPM % | -411.11 | -330.00 | - | -367.57 | -155.74 | - |
| PBDT | 0.10 | 0.28 | -64 | 0.68 | 1.06 | -36 |
| PBT | 0.07 | 0.26 | -73 | 0.58 | 0.96 | -40 |
| NP | 0.03 | -0.07 | LP | 0.44 | 0.32 | 38 |
Powered by Capital Market - Live News